Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00577811 · ClinicalTrials.gov registry record

Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans

A clinical trial of HIV Infections and Mental Health, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
628
Enrollment target
1
Study location

NCT00577811: Completed study of HIV Infections and Mental Health, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00577811 is a study of HIV Infections and Mental Health that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 628 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00577811, a study of HIV Infections and Mental Health, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
628 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out how people's needs are being met and what people do about problems with treatment, symptoms, substance use, mental health, and social services. We are also interested in finding out about changes that people make in their health care team and the reasons for making those changes.

Study Locations (1)

New York

  • Memorial Slaon-Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 628 participants
Start Date 2003-02
Est. Completion 2009-01
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00577811 record still lists

NCT00577811 is an observational study that tracks outcomes without assigning an intervention. The registered 628 participants enrollment target is mid-sized for trials with a published cap, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (41% higher).

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00577811 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00577811 about?

NCT00577811 is a clinical study titled "Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans". The purpose of this study is to find out how people's needs are being met and what people do about problems with treatment, symptoms, substance use, mental health, and social services. We are also interested in finding out about changes that people make in their health care team and the reasons for ...

What is the current status of trial NCT00577811?

This trial is currently completed. The enrollment target is 628 participants. The study started on 2003-02. Estimated completion is 2009-01.

What conditions does trial NCT00577811 study?

This clinical trial studies the following conditions: HIV Infections, Mental Health.

Who is sponsoring clinical trial NCT00577811?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00577811 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00577811's enrollment target sits among peer trials

628 48th of 542 higher than 495 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04704921 · 630 participants · Phase 2

    Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

  • NCT04707729 · 630 participants · NA

    ROX Index for the Timing of Intubation in Nasal High Flow

  • NCT05061550 · 630 participants · Phase 2

    Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • NCT05224440 · 630 participants · NA

    National Sponsorship Program for Transitioning Service Members

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00577811, the US trial registry maintained by the National Library of Medicine. NCT00577811 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.